Cargando…
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)
OBJECTIVE: To determine outcomes of COVID-19 in patients with Multiple Sclerosis (MS) and related conditions, and to determine predictors of these outcomes. METHODS: This was a multicenter, observational cohort study of patients with MS or related CNS autoimmune disorders who developed confirmed or...
Autores principales: | Klineova, Sylvia, Harel, Asaff, Straus Farber, Rebecca, DeAngelis, Tracy, Zhang, Yinan, Hentz, Roland, Leung, Tung Ming, Fong, Kathryn, Smith, Tyler, Blanck, Richard, Zhovtis-Ryerson, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286899/ https://www.ncbi.nlm.nih.gov/pubmed/34392059 http://dx.doi.org/10.1016/j.msard.2021.103153 |
Ejemplares similares
-
COVID-19 and management of neuroimmunological disorders
por: Hartung, Hans-Peter, et al.
Publicado: (2020) -
COVID-19 in children and adolescents with neuroimmunological disorders
por: Pessoa, Ingrid Lacerda, et al.
Publicado: (2022) -
Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders
por: Olivé-Cirera, Gemma, et al.
Publicado: (2021) -
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab
por: Thornton, Jeanine Rempe, et al.
Publicado: (2020) -
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
por: Ferini-Strambi, Luigi, et al.
Publicado: (2020)